Gene · 6372
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancer. | Cell Death Dis | 2023 | 37024472 | PubTator, text mining | PubMed |
| EREG is a risk factor for the prognosis of patients with cervical cancer. | Front Med (Lausanne) | 2023 | 37020674 | PubTator, text mining | PubMed |
| A novel integrative multi-omics approach to unravel the genetic determinants of rare diseases with application in sinusoidal obstruction syndrome. | PLoS One | 2023 | 37018234 | PubTator, text mining | PubMed |
| A key driver to promote HCC: Cellular crosstalk in tumor microenvironment. | Front Oncol | 2023 | 37007125 | PubTator, text mining | PubMed |
| CAFs orchestrates tumor immune microenvironment-A new target in cancer therapy? | Front Pharmacol | 2023 | 37007004 | PubTator, text mining | PubMed |
| A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma. | Front Immunol | 2023 | 37006314 | PubTator, text mining | PubMed |
| Assessment of local and systemic signature of eosinophilic esophagitis (EoE) in children through multi-omics approaches. | Front Immunol | 2023 | 37006253 | PubTator, text mining | PubMed |
| Prospects for targeting ACKR1 in cancer and other diseases. | Front Immunol | 2023 | 37006247 | PubTator, text mining | PubMed |
| Obesity defined molecular endotypes in the synovium of patients with osteoarthritis provides a rationale for therapeutic targeting of fibroblast subsets. | Clin Transl Med | 2023 | 37006170 | PubTator, text mining | PubMed |
| Development of a new HISCL automated CXCL9 immunoassay. | Sci Rep | 2023 | 37005469 | PubTator, text mining | PubMed |
| The stromal-tumor amplifying STC1-Notch1 feedforward signal promotes the stemness of hepatocellular carcinoma. | J Transl Med | 2023 | 37004088 | PubTator, text mining | PubMed |
| Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma. | BMC Cancer | 2023 | 37004045 | PubTator, text mining | PubMed |
| A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease. | Rev Endocr Metab Disord | 2023 | 37000372 | PubTator, text mining | PubMed |
| The protective activity of natural flavonoids against osteoarthritis by targeting NF-κB signaling pathway. | Front Endocrinol (Lausanne) | 2023 | 36998478 | PubTator, text mining | PubMed |
| Arsenic exposure alters the expression of genes related to metabolic diseases in differentiated adipocytes and in newborns and children. | Int J Hyg Environ Health | 2023 | 36989998 | PubTator, text mining | PubMed |
| An Angiogenesis-Related lncRNA Signature Is Associated with Prognosis and Tumor Immune Microenvironment in Breast Cancer. | J Pers Med | 2023 | 36983695 | PubTator, text mining | PubMed |
| Immunology of Multisystem Inflammatory Syndrome after COVID-19 in Children: A Review of the Current Evidence. | Int J Mol Sci | 2023 | 36982783 | PubTator, text mining | PubMed |
| Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics. | Cells | 2023 | 36980203 | PubTator, text mining | PubMed |
| Heterogeneity of Cholangiocarcinoma Immune Biology. | Cells | 2023 | 36980187 | PubTator, text mining | PubMed |
| Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies. | Cells | 2023 | 36980182 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6372/papers?page=26